Intrinsiqq
Intensity Therapeutics Inc. logo

Intensity Therapeutics Inc. Quality Score

INTS

Compare

Could not load quality data

This may be a temporary issue. If it persists, the ticker may not be covered yet.

SourceQuality score computed from the 10-Q filed 4 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 12 Nov 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with INTS

CompareIntrinsic value
ALGSAligos Therapeutics Inc.
$1.22-2.40%10
INMBInmune Bio Inc.
$0.83-7.49%10
CRBUCaribou Biosciences, Inc.
$0.28-8.59%10
KLRSKalaris Therapeutics, Inc.
$1.28-5.19%10
ACOGAlpha Cognition Inc.
$9.00+1.69%10
MGTXMeiraGTx Holdings plc
$7.98-1.97%60
TSHATaysha Gene Therapies Inc.
$3.72-1.33%40
TWSTTwist Bioscience Corporation
$103.32-7.44%40

Spot a number that looks wrong? Check it in INTS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing INTS

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.